It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Perfusion Study

Clinical Trial Title: 
Assessment of cerebral blood flow by quantitative perfusion MRI in patients with spontaneous intracerebral hemorrhage and its effect on DWI abnormalities.
Clinical Trial Protocol ID: 
13061102
Clinical Trial Investigator Name: 
Rajeev K. Garg, MD
Clinical Trial Protocol Description: 

The purpose of this study is to examine the effect reductions in systemic blood pressure have on cerebral perfusion pressure using MRI technology. In patients with reductions in cerebral blood flow, we will also be examining whether these correlate with regions of cerebral ischemia.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Be between 18 and 80 years of age.
  • Have spontaneous ICH.
  • Have no prior history of stroke.

You will be excluded from the study if any of the following criteria apply to you:

  • Have contraindications to contrasted MRI.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Stroke and Cerebrovascular Disease
Contact Phone: 
(312) 942-4500
Contact Name: 
Rajeev K. Garg, MD